RAFAEL HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
RAFAEL HOLDINGS, INC. (RFL) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period of 60.27 thousand shares for the 3-month period ending 2025-10-31, per its 10-Q filed 2025-12-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod · last filed 2025-12-12
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2025-10-31 was 60.27K shares, a 50.79% decline year-over-year.
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2025-07-31 was 256.08K shares, a 8.03% increase year-over-year.
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2025-04-30 was 84.99K shares, a 16.28% increase year-over-year.
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2025-01-31 was 169.91K shares, a 13.72% decline year-over-year.
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2025 was 633.46K shares, a 8.65% increase from fiscal 2024.
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2024 was 583.05K shares, a 21.83% decline from fiscal 2023.
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2023 was 745.87K shares, a 723.18% increase from fiscal 2022.
- RAFAEL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2022 was 90.61K shares, a 30.66% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 12 month |
|---|---|---|---|---|
| 2025-10-31 | 60.27K shares 10-Q · filed 2025-12-12 | 316.35K shares derived: sum of 2 quarters · filed 2025-12-12 | 401.34K shares derived: sum of 3 quarters · filed 2025-12-12 | 571.25K shares derived: sum of 4 quarters · filed 2025-12-12 |
| 2025-07-31 | 256.08K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | 341.07K shares derived: sum of 2 quarters · filed 2025-10-29 | 510.97K shares derived: sum of 3 quarters · filed 2025-10-29 | 633.46K shares 10-K · filed 2025-10-29 |
| 2025-04-30 | 84.99K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-06-11 | 254.89K shares derived: sum of 2 quarters · filed 2025-06-11 | 377.38K shares 10-Q · filed 2025-06-11 | 614.42K shares derived: sum of 4 quarters · filed 2025-06-11 |
| 2025-01-31 | 169.91K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-03-14 | 292.39K shares 10-Q · filed 2025-03-14 | 529.43K shares derived: sum of 3 quarters · filed 2025-03-14 | 602.52K shares derived: sum of 4 quarters · filed 2025-03-14 |
| 2024-10-31 | 122.49K shares 10-Q · filed 2024-12-11 | 359.52K shares derived: sum of 2 quarters · filed 2024-12-20 | 432.61K shares derived: sum of 3 quarters · filed 2024-12-20 | 629.54K shares derived: sum of 4 quarters · filed 2024-12-20 |
| 2024-07-31 | 237.04K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | 310.12K shares derived: sum of 2 quarters · filed 2024-12-20 | 507.05K shares derived: sum of 3 quarters · filed 2024-12-20 | 583.05K shares 10-K/A · filed 2024-12-20 |
| 2024-04-30 | 73.09K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-06-14 | 270.01K shares derived: sum of 2 quarters · filed 2024-06-14 | 346.02K shares 10-Q · filed 2024-06-14 | 582.19K shares derived: sum of 4 quarters · filed 2024-12-20 |
| 2024-01-31 | 196.93K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-03-14 | 272.93K shares 10-Q · filed 2024-03-14 | 509.11K shares derived: sum of 3 quarters · filed 2024-12-20 | 581.97K shares derived: sum of 4 quarters · filed 2024-12-20 |
| 2023-10-31 | 76.00K shares 10-Q · filed 2023-12-14 | 312.18K shares derived: sum of 2 quarters · filed 2024-12-20 | 385.04K shares derived: sum of 3 quarters · filed 2024-12-20 | 776.43K shares derived: sum of 4 quarters · filed 2024-12-20 |
| 2023-07-31 | 236.18K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | 309.04K shares derived: sum of 2 quarters · filed 2024-12-20 | 700.43K shares derived: sum of 3 quarters · filed 2024-12-20 | 745.87K shares 10-K/A · filed 2024-12-20 |
| 2023-04-30 | 72.86K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-13 | 464.25K shares derived: sum of 2 quarters · filed 2023-06-13 | 509.69K shares 10-Q · filed 2023-06-13 | 519.59K shares derived: sum of 4 quarters · filed 2023-10-30 |
| 2023-01-31 | 391.39K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-14 | 436.83K shares 10-Q · filed 2023-03-14 | 446.73K shares derived: sum of 3 quarters · filed 2023-10-30 | 449.96K shares derived: sum of 4 quarters · filed 2023-10-30 |
| 2022-10-31 | 45.44K shares 10-Q · filed 2022-12-13 | 55.34K shares derived: sum of 2 quarters · filed 2023-10-30 | 58.57K shares derived: sum of 3 quarters · filed 2023-10-30 | 132.72K shares derived: sum of 4 quarters · filed 2023-10-30 |
| 2022-07-31 | 9.90K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-30 | 13.13K shares derived: sum of 2 quarters · filed 2023-10-30 | 87.28K shares derived: sum of 3 quarters · filed 2023-10-30 | 90.61K shares 10-K · filed 2023-10-30 |
| 2022-04-30 | 3.23K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-06-14 | 77.38K shares derived: sum of 2 quarters · filed 2022-06-14 | 80.71K shares 10-Q · filed 2022-06-14 | 80.71K shares derived: sum of 4 quarters · filed 2022-10-31 |
| 2022-01-31 | 74.14K shares derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-03-17 | 77.47K shares 10-Q · filed 2022-03-17 | 77.47K shares derived: sum of 3 quarters · filed 2022-10-31 | 117.39K shares derived: sum of 4 quarters · filed 2022-10-31 |
| 2021-10-31 | 3.33K shares 10-Q/A · filed 2022-02-28 | 3.33K shares derived: sum of 2 quarters · filed 2022-10-31 | 43.24K shares derived: sum of 3 quarters · filed 2022-10-31 | 65.65K shares derived: sum of 4 quarters · filed 2022-10-31 |
| 2021-07-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | 39.91K shares derived: sum of 2 quarters · filed 2022-10-31 | 62.32K shares derived: sum of 3 quarters · filed 2022-10-31 | 69.35K shares 10-K · filed 2022-10-31 |
| 2021-04-30 | 39.91K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-06-14 | 62.32K shares derived: sum of 2 quarters · filed 2021-06-14 | 69.35K shares 10-Q · filed 2021-06-14 | 180.34K shares derived: sum of 4 quarters · filed 2021-10-18 |
| 2021-01-31 | 22.41K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-03-17 | 29.43K shares 10-Q · filed 2021-03-17 | 140.43K shares derived: sum of 3 quarters · filed 2021-10-18 | 72.35K shares derived: sum of 4 quarters · filed 2021-10-18 |
| 2020-10-31 | 7.03K shares 10-Q · filed 2020-12-15 | 118.02K shares derived: sum of 2 quarters · filed 2021-10-18 | 49.94K shares derived: sum of 3 quarters · filed 2021-10-18 | |
| 2020-07-31 | 111.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-18 | 42.92K shares derived: sum of 2 quarters · filed 2021-10-18 | 57.06K shares 10-K · filed 2021-10-18 | |
| 2020-04-30 | -68.08K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-09 | -53.94K shares 10-Q · filed 2020-06-09 | ||
| 2020-01-31 | 14.14K shares 10-Q · filed 2020-03-05 | |||
| 2019-07-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-29 | 40.54K shares derived: sum of 2 quarters · filed 2020-10-29 | 57.77K shares derived: sum of 3 quarters · filed 2020-10-29 | 60.01K shares 10-K · filed 2020-10-29 |
| 2019-04-30 | 40.54K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-06-05 | 57.77K shares derived: sum of 2 quarters · filed 2019-06-05 | 60.01K shares 10-Q · filed 2019-06-05 | |
| 2019-01-31 | 17.23K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-03-12 | 19.47K shares 10-Q · filed 2019-03-12 | ||
| 2018-10-31 | 2.25K shares 10-Q · filed 2018-12-10 | |||
| 2018-07-31 | 70.27K shares 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |